EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Recent progress in the treatment of infant acute lymphoblastic leukemia


Pediatrics International 57(5): 811-819
Recent progress in the treatment of infant acute lymphoblastic leukemia
Treatment of infants with acute lymphoblastic leukemia (ALL), especially those with mixed lineage leukemia (MLL) rearrangement (MLL-r), which account for approximately 80% of cases, is still a major challenge for pediatric hematologists and oncologists worldwide. Continuing efforts by collaborative clinical study groups in Europe, North America, and Japan have rescued approximately half of the MLL-r ALL patients with intensive chemotherapy with or without allogeneic hematopoietic stem cell transplantation. Recent progress has clarified the unique mechanism of MLL-r ALL: the aberrant methylation and histone modifications via DOT1L and other related molecules by MLL fusion proteins lead to leukemogenetic gene expression, thus to overt leukemia. In order to overcome this dismal subtype of ALL, novel targeted therapy based on leukemia biology is urgently needed. Due to the extreme rarity of the disease, collaboration between the study groups in Europe (Interfant), North America (Children's Oncology Group), and Japan (Japanese Pediatric Leukemia/Lymphoma Study Group) is under way.


Accession: 058706933

PMID: 26215843

DOI: 10.1111/ped.12758



Related references

Recent progress in the treatment of acute lymphoblastic leukemia: clofarabine. Hematology/Oncology Clinics of North America 23(5): 1137-44, Viii, 2010

Recent progress in the treatment of adult acute lymphoblastic leukemia. Orvosi Hetilap 129(28): 1469-1474, 1988

Recent progress in the treatment of hematological malignancies. II. Acute lymphoblastic leukemia (ALL). Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 78(6): 769-773, 1989

Lymphoid malignancies: progress in diagnosis and treatment. Topics: I. Pathogenesis and pathophysiology--recent findings; 1. Leukemia stem cells in acute lymphoblastic leukemia. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 100(7): 1753-1764, 2011

Childhood relapsed acute lymphoblastic leukemia: Biology and recent treatment progress. Pediatrics International 57(6): 1059-1066, 2015

Leukemia: recent progress in diagnosis and treatment. Topics: III. Diagnosis and treatments: 2. Treatment for acute lymphoblastic leukemia. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(7): 1696-1704, 2013

Recent progress in acute lymphoblastic leukemia in childhood. Japanese Journal of Clinical Hematology 51(10): 1558-1563, 2010

Acute lymphoblastic leukemia in adults: recent progress, future directions. Seminars in Hematology 24(1): 27-39, 1987

Leukemia: recent progress in diagnosis and treatment. Topics: I. Recent findings in pathogenesis and pathophysiology; 1. Acute leukemia stem cells. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(7): 1652-1660, 2013

Treatment outcome in infant acute lymphoblastic leukemia. Children Leukemia Cooperative Group--EORTC. European Organization for Research and Treatment of Cancer. Blood 95(8): 2729-2731, 2000